An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma

• Κύριοι συγγραφείς: Gian Luigi Marseglia (Συγγραφέας), Amelia Licari (Συγγραφέας), Maria Angela Tosca (Συγγραφέας), Michele Miraglia del Giudice (Συγγραφέας), Cristiana Indolfi (Συγγραφέας), Giorgio Ciprandi (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2024-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Severe asthma (SA) is still a demanding challenge in clinical practice. Type 2 inflammation is the most common phenotype in children and adolescents with SA. As a result, anti-inflammatory drugs, mainly corticosteroids (CSs), represent the first choice to reduce type 2 inflammation. However, SA pati...